Embecta rises on US FDA clearance of its insulin patch pump

Embecta

03/09/2024 17:21

** Shares of Embecta  EMBC.O  rise 1.6% to $16.60
    ** Medical device maker says the U.S. FDA has cleared its
disposable insulin patch pump for use in adults who have type 1
or type 2 diabetes
    ** EMBC also plans to submit an application to the FDA for
potential approval of a closed-loop version of its pump with an
insulin-dosing algorithm 
    ** YTD, stock up 12.3% 

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))